Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Acute Postoperative Analgesia (KAPA)
NCT04646694Phase 3Completed
- Sponsor
- University Health Network
- Start
- Nov 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Ketamine Group with Placebo Group (2 arms). Primary endpoint: Recovery After Surgery at 30 days. Started Nov 2020; status: completed.
02
Drugs
ketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04646694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04646694.